Alveron Pharma

Developer of drugs to treat haemorrhagic stroke or intracranial haemorrhage

placeNijmegen, Gelderland, Netherlands calendar_todayFounded 2019 groups3 employees language alveron.com

Innovation

1 patent family (1 granted) — focus: Human necessities; filing pace active. Cited 13 times.

YearFilings
20201
20251

Investor mix

4 investors on record; lead investors include Thuja Capital, Oost NL, Waterman Ventures.

Investor typeCountShare
Venture capital375%
Other / undisclosed125%
Coming soon